Momina A. Qureshi

Neurology

1800 15th St Ste 100B
Greeley, CO 80631

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.

TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: May 01, 2026

TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.

TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

Reversible Cerebral Vasoconstriction Syndrome Secondary to Loperamide Ingestion: A Case Report.

Reversible Cerebral Vasoconstriction Syndrome Secondary to Loperamide Ingestion: A Case Report.

Journal: The Neurohospitalist

Published: April 26, 2024

Effects of developmental exposure to manganese and/or low iron diet: Changes to metal transporters, sucrose preference, elevated zero-maze, open-field, and locomotion in response to fenfluramine, amphetamine, and MK-801.

Effects of developmental exposure to manganese and/or low iron diet: Changes to metal transporters, sucrose preference, elevated zero-maze, open-field, and locomotion in response to fenfluramine, amphetamine, and MK-801.

Journal: Toxicology reports

Published: August 22, 2015

Showing 1-4 of 4

Last Updated: 09/26/2026